Skip to content
10-Q

Quarterly Report

SIGNPATH PHARMA, INC.

0001096906-14-001185

← back to feed
Filed
Aug 18, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2014 · Aug 15, 2014 12.92M sh
Capex Q2 2014 · Jun 30, 2014 $5.39K
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$6.92M
Operating Cash Flow Q2 2014 · Jun 30, 2013 −$790.5K
Stockholders Equity Q2 2014 · Jun 30, 2014 $1.26M
Stockholders Equity Q2 2014 · Dec 31, 2013 $819.77K
Current Liabilities Q2 2014 · Jun 30, 2014 $380.77K
Current Liabilities Q2 2014 · Dec 31, 2013 $421.63K
Current Assets Q2 2014 · Jun 30, 2014 $1.64M
Current Assets Q2 2014 · Dec 31, 2013 $1.24M
Total Assets Q2 2014 · Jun 30, 2014 $1.64M
Total Assets Q2 2014 · Dec 31, 2013 $1.24M
Sga Expense Q2 2014 · Jun 30, 2014 $1.32M
Sga Expense Q2 2014 · Jun 30, 2013 $8.68K
Sga Expense Q2 2014 · Jun 30, 2013 $13.82K
Rd Expense Q2 2014 · Jun 30, 2014 $5.04M
Rd Expense Q2 2014 · Jun 30, 2013 $187.66K
Rd Expense Q2 2014 · Jun 30, 2013 $306.07K
Net Income Q2 2014 · Jun 30, 2014 −$11.83M
Net Income Q2 2014 · Jun 30, 2013 −$413.94K
Net Income Q2 2014 · Jun 30, 2013 −$1.18M
Operating Income Q2 2014 · Jun 30, 2014 −$10.86M
Operating Income Q2 2014 · Jun 30, 2013 −$346.83K
Operating Income Q2 2014 · Jun 30, 2013 −$1.18M